Phenolic compounds from Cotinus coggygria Scop. With alpha glucosidase inhibition
Özet
Diabetes mellitus (DM), characterized by hyperglycemia, is one of the serious metabolic disorders. Inhibiting the key enzymes in digestion of dietary starch such as α-amylase and α-glucosidase, is one of the methods in treatment of DM. Antidiabetic drugs that inhibit carbohydrate-hydrolyzing enzymes have undesired side effects therefore, there is a huge interest in search of medicinal plants. Cotinus coggygria Scop. (Anacardiaceae) is used in Turkish folk medicine to treat DM. Therefore the bioguided fractionation and isolation studies were carried on C. coggygria. The ethyl acetate fraction possessed significative α-glucosidase inhibitory effect with 8.2 µg/mL IC50 value but no meaningful α-amylase inhibitory effect. Gallocatechin (1), methyl gallate (2), myricetin-3-O-α-rhamnoside (3), myricetin-3-O-β-galactoside (4) and 1, 2, 3, 4, 6-penta-O-galloyl-β-glucose (5) were isolated from this active fraction. Compound 5 showed significant α-glucosidase inhibitory activity with 1.5 µg/mL IC50 value, when compared to acarbose (IC50 = 3364.2 µg/mL) which used as positive control. © 2019 Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Özbek, Hilal | |
| dc.contributor.author | Yuca, Hafize | |
| dc.contributor.author | Gözcü, Sefa | |
| dc.contributor.author | Dursunoğlu, Benan | |
| dc.contributor.author | Özenver, Nadire | |
| dc.contributor.author | Güvenalp, Zühal | |
| dc.contributor.author | Kazaz, Cavit | |
| dc.contributor.author | Önal, Mehmet | |
| dc.contributor.author | Demi̇Rezer, L. Ömür | |
| dc.date.accessioned | 2026-10-18T20:29:05.175994831Z | |
| dc.date.available | 2026-10-18T20:29:05.175994831Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Diabetes mellitus (DM), characterized by hyperglycemia, is one of the serious metabolic disorders. Inhibiting the key enzymes in digestion of dietary starch such as α-amylase and α-glucosidase, is one of the methods in treatment of DM. Antidiabetic drugs that inhibit carbohydrate-hydrolyzing enzymes have undesired side effects therefore, there is a huge interest in search of medicinal plants. Cotinus coggygria Scop. (Anacardiaceae) is used in Turkish folk medicine to treat DM. Therefore the bioguided fractionation and isolation studies were carried on C. coggygria. The ethyl acetate fraction possessed significative α-glucosidase inhibitory effect with 8.2 µg/mL IC50 value but no meaningful α-amylase inhibitory effect. Gallocatechin (1), methyl gallate (2), myricetin-3-O-α-rhamnoside (3), myricetin-3-O-β-galactoside (4) and 1, 2, 3, 4, 6-penta-O-galloyl-β-glucose (5) were isolated from this active fraction. Compound 5 showed significant α-glucosidase inhibitory activity with 1.5 µg/mL IC50 value, when compared to acarbose (IC50 = 3364.2 µg/mL) which used as positive control. © 2019 Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved. | |
| dc.description.sponsorship | Acknowledgments: It was funded by The Foundation of Atatürk University (2015/327). The authors thank to Asst. Prof. Songül Karakaya for authentication of the plant material. Benan Dursunoğlu would like to acknowledge the scholarship during her post-graduate program provided by the Turkish Scientific and Technical Research Council (TUBITAK). | |
| dc.identifier.endpage | 132 | |
| dc.identifier.issn | 1300-4182 | |
| dc.identifier.issue | 2 | |
| dc.identifier.scopus | 2-s2.0-85070839366 | |
| dc.identifier.startpage | 127 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14285 | |
| dc.identifier.volume | 44 | |
| dc.language.iso | en | |
| dc.publisher | Society of Pharmaceutical Sciences of Ankara (FABAD) | |
| dc.relation.ispartof | Fabad Journal of Pharmaceutical Sciences | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Anacardiaceae | |
| dc.subject | Cotinus coggygria scop | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Hyperglycemia | |
| dc.subject | α-Amylase inhibition | |
| dc.subject | α-glucosidase inhibition | |
| dc.subject | 1,2,3,4,6 penta o galloyl beta glucose | |
| dc.subject | acarbose | |
| dc.subject | acetic acid ethyl ester | |
| dc.subject | alpha glucosidase | |
| dc.subject | alpha glucosidase inhibitor | |
| dc.subject | amylase | |
| dc.subject | gallic acid methyl ester | |
| dc.subject | gallocatechin | |
| dc.subject | myricetin 3 o alpha rhamnoside | |
| dc.subject | myricetin 3 o beta galactoside | |
| dc.subject | phenol derivative | |
| dc.subject | plant extract | |
| dc.subject | unclassified drug | |
| dc.subject | Article | |
| dc.subject | controlled study | |
| dc.subject | Cotinus coggygria | |
| dc.subject | drug isolation | |
| dc.subject | enzyme inhibition | |
| dc.subject | enzyme inhibition assay | |
| dc.subject | fractionation | |
| dc.subject | IC50 | |
| dc.title | Phenolic compounds from Cotinus coggygria Scop. With alpha glucosidase inhibition | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 10 | |
| rdl.source.index | SCOPUS |
